Discover 3,005 paid clinical trials in Riverside, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,005
Active & Responsive
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
for
Castration Resistant Metastatic Prostate Cancer,
Location: Irvine CA, Omaha NE, Kansas City KS, Grand Rapids MI,
Sponsor: Aktis Oncology, Inc.
Sex: Male
Age: 18+
Code: NCT07581184
Phase 1, Recruiting
Active & Responsive
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
for
Non-Small Cell Lung Cancer, NSCLC,
Location: Irvine CA, Duarte CA, Huntington Beach CA,
Sponsor: Pierre Fabre Medicament
Sex: All
Age: 18+
Code: NCT06043817
Phase 1, Phase 2, Recruiting
Active & Responsive
A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.
for
Locally Advanced Pancreatic Adenocarcinoma,
Location: Irvine CA, Duarte CA, Santa Fe NM, Houston TX,
Sponsor: Xerient Pharma
Sex: All
Age: 18+
Code: NCT07157033
Phase 1, Phase 2, Recruiting
Active & ResponsiveNew
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
for
Migraine
Location: Fullerton CA, Long Beach CA, Canoga Park CA,
Sponsor: Kallyope Inc.
Sex: All
Age: 18 - 70+
Code: NCT07816367
Phase 3, Recruiting
Active & Responsive
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
for
Type 2 Diabetes
Location: Santa Ana CA, Phoenix AZ, Rexburg ID, Redmond WA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT06897475
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System
for
Leadless Pacemaker, Bradycardia, AV Block,
Location: Laguna Hills CA, La Jolla CA, Ventura CA, Burlingame CA,
Sponsor: Biotronik, Inc.
Sex: All
Age: 18+
Code: NCT07118358
Recruiting
Active & Responsive
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Location: Laguna Hills CA, Palm Springs CA, La Jolla CA,
Sponsor: GT Medical Technologies, Inc.
Sex: All
Age: 0+
Code: NCT04427384
Recruiting
Active & Responsive
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
for
Plaque Psoriasis
Location: Santa Ana CA, Fountain Valley CA, Los Angeles CA,
Sponsor: Oruka Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07449702
Phase 2, Recruiting
Active & ResponsiveNew
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
for
Overweight, Obesity
Location: Fullerton CA, Lomita CA, Las Vegas NV, Walnut Creek CA,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07720271
Phase 3, Recruiting
Active & Responsive
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
for
Breast Neoplasms, Brain Neoplasms, Neoplasms by Site, Neoplasms,
Location: Fullerton CA, Los Angeles CA, Houston TX, Urbana IL,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05386108
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
for
Carcinoma, Non-Small-Cell Lung
Location: Fullerton CA, Long Beach CA, Los Angeles CA, Gilbert AZ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06623422
Phase 3, Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
for
Breast Neoplasms
Location: Fullerton CA, Chandler AZ, Gilbert AZ, Denver CO,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06312176
Phase 3, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
for
Crohn's Disease
Location: Orange CA, Anaheim CA, Los Angeles CA, Lancaster CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 16 - 70+
Code: NCT06430801
Phase 3, Recruiting
Active & Responsive
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
for
Genetic Disease
Location: Orange CA, Stanford CA, Seattle WA, Houston TX,
Sponsor: National Human Genome Research Institute (NHGRI)
Sex: All
Age: 0 - 70+
Code: NCT02450851
Recruiting
Active & Responsive
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
for
Overactive Bladder (OAB)
Location: Orange CA, Beverly Hills CA, Los Angeles CA,
Sponsor: FemPulse Corporation
Sex: Female
Age: 21+
Code: NCT07195656
Recruiting
Active & Responsive
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
for
Gastric Adenocarcinoma,
Location: Orange CA, Seattle WA, Dallas TX, Westwood KS,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT05365581
Phase 1, Recruiting
Active & Responsive
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
for
Mesial Temporal Lobe Epilepsy
Location: Orange CA, Los Angeles CA, San Diego CA, Phoenix AZ,
Sponsor: Neurona Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT05135091
Phase 3, Recruiting
Active & Responsive
A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
for
Urothelial Carcinoma
Location: Orange CA, San Francisco CA, Salt Lake City UT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05562830
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study of TAK-505 in Adults With Solid Tumors
for
Malignant Solid Tumors
Location: Orange CA, San Antonio TX, Dallas TX, Houston TX,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT07436728
Phase 1, Phase 2, Recruiting
Active & Responsive
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
for
AML (Acute Myeloid Leukemia), Glioma, Cholangiocarcinoma,